354813-48-2

Basic information

• Product Name: Benzoic acid, 4-(1-methyl-4-piperidinyl)-, methyl ester
• CAS NO: 354813-48-2
• Molecular Formula: C14H19NO2
• Molecular Weight: 233.31
• Mol File: 354813-48-2.mol
• Article Data: 6

Chemical Properties

• CAS DataBase Reference: Benzoic acid, 4-(1-methyl-4-piperidinyl)-, methyl ester(CAS DataBase Reference)
• NIST Chemistry Reference: Benzoic acid, 4-(1-methyl-4-piperidinyl)-, methyl ester(354813-48-2)
• EPA Substance Registry System: Benzoic acid, 4-(1-methyl-4-piperidinyl)-, methyl ester(354813-48-2)

Safety Data

• Hazardous Substances Data: 354813-48-2(Hazardous Substances Data)

Upstream product

• 771-99-3 4-phenylpiperidine 
• 196204-01-0 4-(piperidin-4-yl)-benzoic acid 
• 286961-15-7 benzyl 4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-3,6-dihydro-1 (2H)-pyridinecarboxylate 
• 586-76-5 4-Bromobenzoic acid 
• 50-00-0 formaldehyd 
• 281235-04-9 methyl 4-(piperidine-4-yl)benzoate 
• 1453272-47-3 ethyl 4-(piperidin-4-yl)benzoate hydrochloride 
• 180912-08-7 4-(4-bromophenyl)-1-methyl-1,2,3,6-tetrahydropyridine 
• 139474-25-2 4-(4-bromophenyl)-1-methylpiperidin-4-ol 
• 1445-73-4 1-Methyl-4-piperidone 
• 67-56-1 methanol 
• 79-37-8 oxalyl dichloride 
• 774-52-7 1-methyl-4-phenylpiperidine 
• 106-37-6 1.4-dibromobenzene 

Downstream Products

• 1035269-77-2 N-[5-[2-(3,5-dimethoxyphenyl)ethyl]-1H-pyrazol-3-yl]-4-(1-methyl-4-piperidyl)benzamide 
• 1071756-46-1 C₁₃H₁₉NO 
• 1276024-93-1 (4-(1-methylpiperidin-4-yl)phenyl)carbaldehyde 
• 354813-49-3 4-(1-methylpiperidin-4-yl)benzoic acid 

Relevant articles and documents

BENZO- AND PYRIDO-PYRAZOLES AS PROTEIN KINASE INHIBITORS

The invention relates to new chemical compounds of Formula (I), pharmaceutical compositions containing them, and their use for the pharmacological treatment of a cancer, preferably a glioblastoma.

AMIDO SPIROCYCLIC AMIDE AND SULFONAMIDE DERIVATIVES

Provided are amido spirocyclic amide and sulfonamide compounds, pharmaceutical compositions comprising such compounds, and methods of treatment using such compounds.

NOVEL COMPOUNDS

There is provided a compound of formula (I): or a pharmaceutically acceptable salt thereof. There are also provided processes for the manufacture of a compound of Formula 1, and the use of a compound of Formula 1 as a medicament and in the treatment of cancer.